Zobrazeno 1 - 10
of 89
pro vyhledávání: '"Róbert, Sepp"'
Publikováno v:
Cardiologia Hungarica, Vol 54, Iss 4, Pp 294-301 (2024)
Mineralocorticoid receptor antagonists (MRAs) have proven to be highly effective therapeutic options in the treatment of patients with heart failure with reduced ejection fraction (HFrEF) based on randomized clinical trials. Current evidence in these
Externí odkaz:
https://doaj.org/article/2538bc677f884ef5b4d0aca916b66075
Publikováno v:
Cardiologia Hungarica, Vol 54, Iss 4, Pp 286-293 (2024)
Since the publication of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure (HF), results of several randomized controlled clinical trials have been published that have a direct impact on day-to-day clinical pr
Externí odkaz:
https://doaj.org/article/98c017874e234ee6a567f280ee3d223b
Autor:
Balázs Solymossi, Balázs Muk, Róbert Sepp, Tamás Habon, Attila Borbély, Krisztina Heltai, Zsuzsanna Majoros, Zoltán Járai, Dénes Vágány, Ákos Szatmári, Erzsébet Sziliczei, Fanni Bánfi‐Bacsárdi, Noémi Nyolczas
Publikováno v:
ESC Heart Failure, Vol 11, Iss 2, Pp 783-794 (2024)
Abstract Aims The aim of the study was to assess the incidence and predictive factors of the development of heart failure with improved ejection fraction (HFimpEF) category during a 1 year follow‐up period in a heart failure with reduced ejection f
Externí odkaz:
https://doaj.org/article/390d534829ba4d03a7f5916c0194032f
Autor:
András Vereckei, Gábor Katona, Gábor Szénási, László Dániel Vidács, Dóra Földeák, Hedvig Takács, Viktória Nagy, Róbert Sepp
Publikováno v:
ESC Heart Failure, Vol 11, Iss 2, Pp 1030-1038 (2024)
Abstract Aims The early diagnosis of cardiac amyloidosis (CA) is paramount, since there are effective therapies that improve patient survival. The diagnostic accuracy of classical electrocardiographic (ECG) signs, such as low voltage, pseudoinfarct p
Externí odkaz:
https://doaj.org/article/841333185270492497a5bc63434c9040
Autor:
András Vereckei, Gábor Katona, Katalin Révész, Hajnalka Vágó, Veronika Müller, Beáta Nagy, Péter Nagy, Róbert Sepp, Kim Suvarna
Publikováno v:
ESC Heart Failure, Vol 9, Iss 6, Pp 4304-4314 (2022)
Abstract Cardiac sarcoidosis (CS) is a chameleon of cardiology, and it can mimic different cardiac diseases; among them is arrhythmogenic cardiomyopathy (ACM). We admitted a 70‐year‐old female patient with heart failure symptoms in 2015, who fulf
Externí odkaz:
https://doaj.org/article/5358113879fb4ab6a0d67d4ddda2c17e
Autor:
András Vereckei, Zsuzsanna Besenyi, Viktória Nagy, Bence Radics, Hajnalka Vágó, Zsigmond Jenei, Gábor Katona, Róbert Sepp
Publikováno v:
Reviews in Cardiovascular Medicine, Vol 25, Iss 2, p 37 (2024)
Sarcoidosis is an inflammatory multisystemic disease of unknown etiology characterized by the formation of non-caseating granulomas. Sarcoidosis can affect any organ, predominantly the lungs, lymphatic system, skin and eyes. While >90% of patients wi
Externí odkaz:
https://doaj.org/article/ef8025a8515e444aab4c1baeaa5a15a0
Autor:
János Borbás, Máté Vámos, Lidia Hategan, Lilla Hanák, Nelli Farkas, Zsolt Szakács, Dezső Csupor, Bálint Tél, Péter Kupó, Beáta Csányi, Viktória Nagy, András Komócsi, Tamás Habon, Péter Hegyi, Róbert Sepp
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundMutations in the CACNA1C gene–encoding for the major Ca2+ channel of the heart–may exhibit a variety of clinical manifestations. These include typical or atypical Timothy syndromes (TS) which are associated with multiple organ manifesta
Externí odkaz:
https://doaj.org/article/c23cb777b70e448883f2ed89517116a6
Autor:
Gergely Rácz, Hedvig Takács, Árpád Kormányos, Bianka Polestyuk, János Borbás, Nándor Gyenes, Noémi Schvartz, Gergely Németh, Zsigmond Tamás Kincses, Róbert Sepp, Viktória Nagy
Publikováno v:
Diagnostics, Vol 12, Iss 8, p 1941 (2022)
Although the clinical manifestations of SARS-CoV-2 viral infection affect mainly the respiratory system, cardiac complications are common and are associated with increased morbidity and mortality. While echocardiographic alterations indicating myocar
Externí odkaz:
https://doaj.org/article/e98b822476a34f678c1c8439e9ca5cdf
Autor:
Daniella Nagy, Katalin Révész, Gergely Peskó, Gergely Varga, Laura Horváth, Péter Farkas, András Dávid Tóth, Róbert Sepp, Hajnalka Vágó, Anikó Ilona Nagy, Tamás Masszi, Zoltán Pozsonyi
Publikováno v:
Biomedicines, Vol 10, Iss 7, p 1765 (2022)
Background: Cardiac amyloidosis (CA) is a rare, progressive, infiltrative cardiac disease. Light chain (AL) and transthyretin (ATTR) amyloidosis are in the background in almost all cases. New, easily available diagnostic tools and recently introduced
Externí odkaz:
https://doaj.org/article/d0a0aaac6355448b968d9a6be5f6c409
Autor:
Róbert Sepp, Lidia Hategan, Beáta Csányi, János Borbás, Annamária Tringer, Eszter Dalma Pálinkás, Viktória Nagy, Hedvig Takács, Dóra Latinovics, Noémi Nyolczas, Attila Pálinkás, Réka Faludi, Miklós Rábai, Gábor Tamás Szabó, Dániel Czuriga, László Balogh, Róbert Halmosi, Attila Borbély, Tamás Habon, Zoltán Hegedűs, István Nagy
Publikováno v:
Diagnostics, Vol 12, Iss 5, p 1132 (2022)
Hypertrophic cardiomyopathy (HCM) is a primary disease of the myocardium most commonly caused by mutations in sarcomeric genes. We aimed to perform a nationwide large-scale genetic analysis of a previously unreported, representative HCM cohort in Hun
Externí odkaz:
https://doaj.org/article/6362fa260e40429f98fc1d13dc6de1c2